1. Introduction {#s0005}
===============

Trichotillomania, also known as hair-pulling disorder, is characterized by the repetitive pulling out of one\'s own hair, leading to significant functional impairment ([@bb0010]). The condition has lifetime prevalence of 0.5--1% based on surveys, yet is often hidden, undiagnosed and untreated ([@bb0115], [@bb0240]). Trichotillomania has peak age of onset in adolescence, is more common in women than in men, and is currently classified as an Obsessive-Compulsive Related Disorder ([@bb0110]). However, in contrast to the repetitive compulsive acts observed in obsessive-compulsive disorder (OCD), repetitive behaviors in trichotillomania are not generally driven by intrusive thoughts. As such, and in view of the recent development of animal models with good validity ([@bb0050], [@bb0125], [@bb0130]), trichotillomania constitutes a key model for better understanding compulsive symptoms more generally. However, surprisingly little is known about the neurobiological basis of this disorder in humans ([@bb0070], [@bb0075], [@bb0150], [@bb0165]).

Reviewing available clinical and imaging studies of trichotillomania, previous work suggested an "ABC" model of trichotillomania emphasizing the dysfunction of pathways involved in Affect regulation, Behavioral Control, and Cognition ([@bb0225]). This approach implicates, in turn, the frontal cortices (serving to regulate impulses and habits), the amygdala (involved in emotional processing) ([@bb0030]), and the striatum (playing key roles in reward processing and motor outflow) ([@bb0005], [@bb0140]). In keeping with this, studies have found that trichotillomania is associated with impairment on response inhibition tests ([@bb0040], [@bb0170]), and phenomenological studies have found relationships between emotional states (dysphoria, anxiety) and the severity of the hair-pulling symptoms ([@bb0120]).

Neuroimaging constitutes a core modality through which to evaluate implicated neural regions in patients with trichotillomania. Structural imaging studies comparing patients with trichotillomania to controls have yielded mixed results with regards to the basal ganglia. One study found no volumetric changes in the caudate ([@bb0220]), one found no difference in the global basal ganglia ([@bb0200]), one found reduced left putamen volumes ([@bb0180]), and another found excess grey matter density in left putamen and amygdala ([@bb0055]). Due to the relatively limited research scrutiny of this disorder, and limited funding, imaging studies have typically involved relatively small sample sizes. Small sample sizes result in limited statistical power and elevate the risk of false positive findings ([@bb0025]). Subcortical structures are difficult to visualize due to poor and variable signal intensity (as compared to cortex) ([@bb0185]) and several mainstream imaging analysis pipelines were designed for analysis of cortex rather than subcortical regions ([@bb0080]). More recent pipelines enable the sensitive measurement not only of volumes of subcortical structures, but also of local differences in deformations of shape across groups; the latter has the advantage of not relying on arbitrary smoothing extent or tissue classification ([@bb0185]).

Therefore, the current study pooled together raw MRI scans from all available peer-reviewed case-control studies of trichotillomania, and evaluated the volume and morphology of select subcortical structures. Software pipelines, including "vertex analysis" from FMRIB\'s Software Library (FSL) were used, these being designed specifically for the sensitive measurement of subcortical structures ([@bb0185]). We hypothesized that trichotillomania would be associated with volumetric and morphometric abnormalities of the caudate, putamen, nucleus accumbens, and amygdala ([@bb0225]).

2. Material and methods {#s0010}
=======================

2.1. Data collection of participants {#s0015}
------------------------------------

Conventional cortical data for the current sample were reported previously and the MRI dataset obtained here was the same as that used by the previous study ([@bb0060]). In brief, all structural MRI studies regarding trichotillomania were identified via PubMed in February 2017. We contacted the authors of these publications and invited them to contribute de-identified MRI scans from published studies, subject to original participants providing appropriate consent and Institutional Board Approvals. De-identified T1-weighted MRI images and demographic data were shared for patients and controls. Demographic data consisted of age, gender, level of education, medication status, and severity of illness measured with the Massachusetts General Hospital Hair Pulling Scale (MGH-HPS) ([@bb0135]), which is a self-administered questionnaire assessing severity of trichotillomania. We excluded trichotillomania patients who were taking psychotropic medication at the time of study participation, to avoid potentially confounding effects of medication on brain structure ([@bb0155]). This applied to six patients.

2.2. Data analysis {#s0020}
------------------

Group differences in demographic data were explored with independent sample *t*-tests (p \< 0.05, two-tailed, uncorrected) and chi-square tests (p \< 0.05), using JMP Pro.

Imaging pre-processing and data extractions were undertaken on the University of Chicago Midway computing system. The T1-weighted images of each subject were preprocessed. They were automatically bias-field corrected and non-linearly registered to the MNI 152 standard space. We employed FMRIB\'s Integrated Registration and Segmentation Tool (FIRST) implemented in FSL 5.0.9 to automatically segment subcortical structures ([@bb0185]). Segmentation was based on shape models with structural boundaries obtained from 336 manually segmented images, and resulted in a deformable surface mesh of each subcortical structure consisting of vertices. The meshes were reconstructed and filled in MNI space and boundary correction was applied. Then, the segmented images were transformed into original space. All segmented images were visually checked for errors in registration and segmentation and the images of 2 trichotillomania patients were discarded due to poor quality in segmentation.

### 2.2.1. Volumetric analysis {#s0025}

Subcortical volumes of the bilateral nucleus accumbens, amygdala, caudate, and putamen were extracted. These regions of interest were selected based on extant models of the pathophysiology of trichotillomania ([@bb0225]). We calculated total intracranial volume (ICV) as the sum volumes of grey matter, white matter and cerebrospinal fluid using FMRIB\'s Automated Segmentation Tool (FAST) ([@bb0245]). Each subject\'s brain scan was skull-stripped with the Brain Extraction Tool and linearly aligned to the MNI152 space, and the inverse of the determinant of the affine transformation matrix computed by the software was multiplied by the ICV size of the template. We adjusted the subcortical volumes by the ICV of each patient ([@bb0020]). The adjusted volumes of each participant were exported into JMP Pro Version 13.1.0. Group differences in ICV-corrected subcortical volumes were explored using independent sample *t*-tests. Statistical significance was defined as p \< 0.05 two-tailed, Bonferroni corrected. Correlations between MGH-HPS scores and subcortical volumes were analyzed in trichotillomania participants, using Spearman\'s rho. For correlation analyses, significance was defined as p \< 0.05 two-tailed uncorrected.

### 2.2.2. Vertex analysis {#s0030}

Vertex analysis, implemented in FIRST, (FSL), was employed to compare the shapes of the subcortical structures between groups ([@bb0185]). The vertex locations of each participant were projected onto the surface normal of the average shape template of the 336 training subjects provided by FSL, and the perpendicular distance from the average surface was calculated. Negative value of the vertex represented deformation in the inward direction and positive value of a vertex indicated deformation in the outward direction. These values were compared between groups using 'Randomise', a permutation-based non-parametric testing method implemented in FSL with 5000 iterations ([@bb0235]). The statistical images were produced with Threshold-Free Cluster Enhancement (TFCE) for multiple comparisons ([@bb0215]), in which threshold was set at p \< 0.05.

3. Results {#s0035}
==========

3.1. Demographics {#s0040}
-----------------

The final study sample comprised 68 individuals with trichotillomania and 41 healthy controls. The mean total Massachusetts General Hospital Hair Pulling Scale severity score in the trichotillomania group was 15.6 (standard deviation 4.7), consistent with, on average, mild-moderate illness. There were no significant differences in age, gender, education level, total grey and white matter volumes, or total intracranial volume, between the groups ([Table 1](#t0005){ref-type="table"}).Table 1Comparison of demographics and clinical characteristics in the trichotillomania and healthy control groups. Groups did not differ significantly on these measures (all p \> 0.10).Table 1TrichotillomaniaHealthy controlsStatisticp-Value(N = 68)(N = 41)Age (mean, SD)33.49 (11.78)32.42 (10.76)0.48[a](#tf0005){ref-type="table-fn"}0.64Gender (N, %) Male6 (8.8%)5 (12.2%)0.32[b](#tf0010){ref-type="table-fn"}0.57 Female62 (91.2%)36 (87.8%)Education (N, %) High school or less6 (8.8%)5 (12.5%)0.40[b](#tf0010){ref-type="table-fn"}0.82 College/lower degree15 (22.1%)9 (22.5%) Graduate/higher degree47 (69.1%)26 (65.0%)Total grey matter volume, mm^3^571,505 (54517)565,064 (45568)0.63[a](#tf0005){ref-type="table-fn"}0.53Total white matter volume, mm^3^507,156 (49080)498,500 (43328)0.93[a](#tf0005){ref-type="table-fn"}0.35Total intracranial volume, mm^3^1,343,947 (107840)1,330,783 (103409)0.63[a](#tf0005){ref-type="table-fn"}0.53[^1][^2][^3]

3.2. Volumetric analysis {#s0045}
------------------------

Absolute volumetric data of subcortical grey matter regions were listed and results of group comparisons are shown in [Table 2](#t0010){ref-type="table"}. With correction for multiple comparisons, patients had significantly smaller ICV-corrected subcortical volumes compared to controls in the right amydala (t = − 2.84, uncorrected p = 0.005, corrected p = 0.04) and in the left putamen (t = − 2.99, uncorrected p = 0.004, corrected p = 0.032). There were trends toward volumetric reductions in other subcortical regions, but these did not withstand correction for multiple comparisons ([Table 2](#t0010){ref-type="table"}). Volumes of subcortical regions did not correlate significantly with symptom severity in the trichotillomania cases (all p \> 0.05 uncorrected).Table 2Comparison of subcortical volumes among individuals with trichotillomania and healthy controls. \*p \< 0.05, \*\*p \< 0.01 significantly smaller volumes in patients compared to controls with Bonferroni correction.Table 2Subcortical structures*t*-testUncorrected p-valueRaw volume of subcortical structures (SD), mm^3^Trichotillomania (N = 68)Healthy controls (N = 41)Lt. Amygdala− 2.310.0241183.97 (293.59)1308.31 (289.79)Rt. Amygdala− 2.840.005\*1159.68 (294.21)1309.58 (272.03)Lt. Putamen− 2.990.004\*5034.06 (737.89)5366.68 (664.66)Rt. Putamen− 2.710.0084996.79 (597.69)5222.66 (547.46)Lt. Caudate− 1.800.0753458.6 (482.0)3575.0 (430.0)Rt. Caudate− 1.250.2163640.5 (443.9)3712.2 (429.2)Lt. Nuc. Accumbens− 1.910.059553.0 (139.4)594.0 (109.9)Rt. Nuc. Accumbens− 1.750.084434.0 (118.6)470.8 (115.0)

3.3. Vertex analysis {#s0050}
--------------------

The results of vertex-wise shape analysis are shown in [Fig. 1](#f0005){ref-type="fig"}. The analysis revealed localized shape deformities in trichotillomania patients versus controls in the right putamen, right caudate, bilateral nucleus accumbens, and bilateral amygdala.Fig. 1Significant deformations of subcortical structures in patients with trichotillomania compared to controls, at p \< 0.05 corrected by permutation tests. In blue, localized surface contractions in patients; in red, localized surface expansions in patients. Template outlines of structures are shown in green.Fig. 1

4. Discussion {#s0055}
=============

This study elucidated subcortical structural characteristics in trichotillomania, using pooled MRI data from available peer-reviewed imaging studies, coupled with statistical pipelines designed to overcome problems in visualizing such non-cortical structures. The main findings were that, compared to matched healthy volunteers, trichotillomania patients had (i) significant volume reductions of the right amygdala and left putamen; and (ii) localized morphometric (curvature) abnormalities of the putamen, caudate, nucleus and amygdala.

The putamen is the key component in motor control and is involved in habit learning and response suppression across species ([@bb0160]). While the caudate plays a role in directed-learning (such as during complex planning or high-level flexible learning tasks), the putamen is more involved in lower-level stimulus-response habit learning ([@bb0105]). The macroscopic changes in putamen but not caudate volume associated with trichotillomania may help to account for why co-morbidity free patients with trichotillomania manifest response inhibition deficits (involving simple stimulus-response mappings ([@bb0170])) while other cognitive domains are relatively spared (e.g. executive planning, set-shifting ([@bb0045])). We suggest that the more pronounced changes in the putamen are also in keeping with trichotillomania being a disorder of motor habit, rather than the symptoms being primarily driven by cognitions or more complex sequencing ([@bb0105]). Abnormalities of the putamen have also been implicated in tic spectrum disorders including Tourette\'s syndrome ([@bb0210]). In a recent study of patients with tics, un-medicated patients relied on not goal-directed but rather on habitual behavioral control, and showed stronger structural connectivity between the supplementary motor cortex and putamen ([@bb0090]). Healthy volunteer studies support a role for dopamine D2 receptors in the putamen in regulating response inhibition ([@bb0100]), which may in turn support a role for dorsal striatum dopamine receptors in the pathophysiology of trichotillomania, with potential treatment implications.

In addition to macroscopic volume changes in the left putamen, we also found here that the right amygdala was abnormally small in patients with trichotillomania compared to healthy controls. The amygdala was traditionally held to be important in fear-processing ([@bb0175]), but more recent work highlights its involvement in a broader range of processes, including arousal, attention, value representation and decision-making ([@bb0145], [@bb0195]). Negative affective states can directly contribute to and trigger hair-pulling symptoms ([@bb0070]), and individuals with trichotillomania showed decreased functional connectivity of amygdala within the reward network ([@bb0230]). It has also been suggested that hair-pulling may serve to regulate arousal levels: for some individuals, hair-pulling may be undertaken during times of boredom or low activity (e.g. watching television); while for others, hair-pulling may be soothing and undertaken during times of stress and arousal (e.g. work stress ([@bb0225])).

Using an imaging pipeline that generated a mesh, representing the curvature (three-dimensional morphology) of subcortical structures, there was evidence for localized abnormalities in the curvature of the amygdala, putamen, caudate, and nucleus accumbens, in trichotillomania patients compared to the controls. This is the first study to examine localized structural changes in this disorder. These findings should be viewed as being more subtle than the macroscopic differences described above, and thus warrant replication in future work. Interestingly, the nucleus accumbens plays a role in impulsivity ([@bb0085]) including in temporal reward discounting ([@bb0035]) and premature responding ([@bb0065]). In a previous functional neuroimaging study, individuals with trichotillomania showed decreased activation of nucleus accumbens during reward anticipation ([@bb0230]). It has also been suggested that caudate and the subthalamic nucleus have important roles in response inhibition performance ([@bb0095]), as well as the putamen.

Several limitations in the present study should be considered. First, demographic and clinical data were limited to a few key measures, because the study pooled data from different research programs. It would be valuable to explore relationships between the structural abnormalities found here and other measures (such as cognitive functioning, and questionnaires pertaining to affect dysregulation). Second, the current study did not evaluate any effects of psychotropic medication on brain structure in trichotillomania -- we excluded patients taking medications. There is no widely accepted pharmacological 'standard of care' for this disorder ([@bb0205]), which means that evaluation of medication effects would likely be a moot point in the absence of large data using evidence-based pharmacological treatments. Third, the findings here differ from those we reported previously in an overlapping sample ([@bb0060]). In this previous work, we focused on cortical structure but also reported select subcortical volumes extracted using the Freesurfer pipeline, and group differences were not significant. The current study used the FIRST algorithm, which appears superior to Freesurfer for analysis of at least some subcortical structures (notably putamen) in terms of accuracy ([@bb0190]). Thus viewed together, the findings suggest that FIRST may be more sensitive to subcortical changes in trichotillomania. It is also interesting to note that the variability (standard deviations) were somewhat larger in the Freesurfer study for subcortical regions, which may again suggest lower precision for this alternative imaging pipeline as pertains to subcortical structures. Finally, by pooling scans from multiple sites, we were able to achieve a larger sample size; however, the sample size was still relatively small compared to mega-analyses available for other related disorders (e.g. OCD) ([@bb0015]).

5. Conclusion {#s0060}
=============

In summary, this analysis found subcortical brain abnormalities in trichotillomania: reduced putamen and amygdala volumes coupled with more subtle localized changes in the curvature of the putamen, caudate, accumbens, and amygdala. Thus, abnormalities of neural nodes mediating affect regulation, reward-processing, and habit generation, all appear to be involved in the pathophysiology of trichotillomania. Future work should examine the temporal course of these changes and their genetic underpinnings (potential heritability): it may be that some changes constitute vulnerability markers but others are secondary to the symptoms (or reflect compensatory changes during brain development). From a treatment perspective, it is interesting that *n*-acetyl cysteine (an amino-acid precursor), a glutamatergic medication, has efficacy in the treatment of trichotillomania. *N*-acetyl cysteine is an amino acid precursor that restores extracellular levels of glutamate in the nucleus accumbens in animal models of substance use. Given the role of D2 dopamine receptors in mediating response inhibition in the striatum ([@bb0100]), and beneficial effects seen in trichotillomania with olanzapine, the current results may hint at why only certain medications appear to have efficacy in treating this neglected disorder.
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[^1]: Abbreviations: SD = standard deviation.

[^2]: Independent sample *t*-tests.

[^3]: Chi-square tests.
